May 2, 2014 / 6:45 AM / 4 years ago

AstraZeneca says board will review Pfizer offer

LONDON (Reuters) - AstraZeneca’s board will be reviewing a sweetened takeover offer from Pfizer but the company has no further comment at this stage, a spokeswoman for the British drugmaker said on Friday.

Earlier the U.S. drugmaker revealed it had raised its offer for the British group to 63 billion pounds ($106 billion).

Reporting by Ben Hirschler; editing by Kate Holton

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below